Genetics could factor into racial disparity in colon cancer

Genetics May Explain Racial Disparity in Colon CA Outcome
Genetics May Explain Racial Disparity in Colon CA Outcome

(HealthDay News) -- Genetic differences may contribute to the higher mortality associated with colon cancer in African-Americans compared with Caucasians, according to research published online June 23 in PLOS ONE.

John M. Carethers, M.D., of the University of Michigan in Ann Arbor, and colleagues examined the prevalence of microsatellite instability (MSI) and associated CD8+ T cell infiltration within the cancers for a population-based cohort of 503 patients (45 percent African-American) with colon cancer.

The researchers found that, among Caucasian patients with colon cancer, 14 percent of the cancers showed MSI compared with 7 percent in African-Americans (P = 0.009). Clinically, no differences in MSI cancers were observed between the races. For patients with microsatellite stable cancers, African-American patients were more likely to be younger and female and have proximal cancers, compared to Caucasian patients. CD8+ T cell infiltration was significantly greater in MSI cancers, but no difference was observed according to race.

"Utilizing this population-based cohort, African-American cancers show half the MSI prevalence of Caucasians without change in CD8+ T cell infiltration which may contribute towards their higher mortality from colon cancer," the authors write.

Full Text (subscription or payment may be required)

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs